Abstract
Chemotherapy-Induced peripheral neuropathy is rapidly becoming a growing problem faced by healthcare processionals and individuals living with and beyond cancer. The incidence of cancer diagnoses is increasing and, as a result, so is the incidence of individuals living with the consequences of cancer treatment. Chemotherapy-induced peripheral neuropathy is a complex symptom, and its incidence and impact on quality of life varies across treatment modalities. This complexity continues into its assessment and management, and healthcare professionals require more support and guidance when presented with this pain state. This article will explore the current literature surrounding assessment methods and management strategies that will enable prescribers to make informed decision when encountering chemotherapy-induced peripheral neuropathy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
